Tag Archives: Tiprelestat

tiakis Biotech announced the results of its randomized, double-blind, placebo-controlled clinical Phase Ib/II COMCOVID trial evaluating Tiprelestat for the treatment of patients hospitalized due to COVID.

Read More »